Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Cardiovascular Diseases | 0.020 | 0.500 | 2 | 2014 | 2015 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.030 | 0.667 | 3 | 2010 | 2017 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.060 | 1.000 | 6 | 2009 | 2017 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.060 | 1.000 | 6 | 2009 | 2017 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.050 | 1.000 | 5 | 2007 | 2013 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2011 | 2018 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2011 | 2018 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.020 | 1.000 | 2 | 2009 | 2018 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2007 | 2018 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2009 | 2018 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
0.020 | 1.000 | 2 | 2007 | 2018 | ||||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2009 | 2011 | |||||||
|
0.611 | 0.600 | 10 | 44372809 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||||
|
0.827 | 0.160 | 10 | 44376100 | intron variant | G/A;T | snv | 0.21 |
|
Pathological Conditions, Signs and Symptoms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||||
|
0.851 | 0.200 | 10 | 44378805 | intron variant | C/T | snv | 0.32 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2009 | 2015 | |||||||
|
0.851 | 0.200 | 10 | 44378805 | intron variant | C/T | snv | 0.32 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2009 | 2015 | |||||||
|
0.851 | 0.200 | 10 | 44378805 | intron variant | C/T | snv | 0.32 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2009 | 2015 | |||||||
|
1.000 | 0.080 | 10 | 44371698 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.040 | 10 | 44370528 | 3 prime UTR variant | A/G | snv | 5.4E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.040 | 10 | 44370528 | 3 prime UTR variant | A/G | snv | 5.4E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.040 | 10 | 44370528 | 3 prime UTR variant | A/G | snv | 5.4E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 44381138 | intron variant | T/A;C | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 10 | 44381138 | intron variant | T/A;C | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.080 | 10 | 44345031 | regulatory region variant | G/A;C | snv |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2009 | 2009 |